MedEdTalks - Gastroenterology-logo

MedEdTalks - Gastroenterology

Science Podcasts >

MedEdTalks Gastroenterology is a continuing medical education podcast for physicians to allow them to learn while on the go and obtain CME credits. This show will focus in on gastroenterology topics, such as ulcerative colitis (UC) and Crohn’s disease and includes interviews with Dr. Peter Higgins from the University of Michigan, Dr. David Rubin from the University of Chicago and Dr. William Sandborn from the University of California, San Diego.

MedEdTalks Gastroenterology is a continuing medical education podcast for physicians to allow them to learn while on the go and obtain CME credits. This show will focus in on gastroenterology topics, such as ulcerative colitis (UC) and Crohn’s disease and includes interviews with Dr. Peter Higgins from the University of Michigan, Dr. David Rubin from the University of Chicago and Dr. William Sandborn from the University of California, San Diego.
More Information

Location:

United States

Description:

MedEdTalks Gastroenterology is a continuing medical education podcast for physicians to allow them to learn while on the go and obtain CME credits. This show will focus in on gastroenterology topics, such as ulcerative colitis (UC) and Crohn’s disease and includes interviews with Dr. Peter Higgins from the University of Michigan, Dr. David Rubin from the University of Chicago and Dr. William Sandborn from the University of California, San Diego.

Language:

English

Contact:

8569949400


Episodes

Investigational Agents in Ulcerative Colitis: IL-12 and IL-23 Inhibitors

4/29/2019
More
Investigational Agents in Ulcerative Colitis: IL-12 and IL-23 InhibitorsInflammatory bowel disease, which includes ulcerative colitis (UC) and Crohn’s disease, affects an estimated 3 million adults in the United States. Although numerous therapies are available for the treatment of moderate to severe UC, many patients still suffer poor quality of life and suboptimal outcomes. Therefore, safer and more effective UC therapies are needed. In this CME podcast activity, Dr. Peter Higgins and...

Duration:00:12:24

Investigational Agents in Ulcerative Colitis: JAK Inhibitors and S1P Receptor Modulators

4/29/2019
More
Inflammatory bowel disease, which includes ulcerative colitis (UC) and Crohn’s disease, affects an estimated 3 million adults in the United States. Although numerous therapies are available for the treatment of moderate to severe UC, many patients still suffer poor quality of life and suboptimal outcomes. Therefore, safer and more effective UC therapies are needed. In this CME podcast activity, Dr. Peter Higgins and Dr. William Sandborn will discuss investigational Janus kinase inhibitors...

Duration:00:09:11

Investigational Agents in Ulcerative Colitis: Anti-Integrins

4/25/2019
More
Inflammatory bowel disease, which includes ulcerative colitis (UC) and Crohn’s disease, affects an estimated 3 million adults in the United States. Although numerous therapies are available for the treatment of moderate to severe UC, many patients still suffer poor quality of life and suboptimal outcomes. Therefore, safer and more effective UC therapies are needed. In this CME podcast activity, Dr. David Rubin and Dr. Peter Higgins will discuss investigational anti-integrin therapies for...

Duration:00:09:36

Ulcerative Colitis: Targeting Immunological Pathways in Moderate to Severe Disease – Updates From Copenhagen

4/25/2019
More
Inflammatory bowel disease, which includes ulcerative colitis (UC) and Crohn’s disease, affects an estimated 3 million adults in the United States. Although numerous therapies are available for the treatment of moderate to severe UC, many patients still suffer poor quality of life and suboptimal outcomes. Therefore, safer and more effective UC therapies are needed. In this CME podcast activity, expert physicians will discuss investigational UC therapies with various mechanisms of...

Duration:00:00:47